A Fourth Dose of the COVID-19 Vaccine May Be Necessary, the Pfizer CEO Says
CEO Albert Bourla recently spoke about the vaccine while appearing on "Face the Nation."
"Right now, the way that we have seen, it is necessary, a fourth booster right now," he said. "The protection that you are getting from the third, it is good enough, actually quite good for hospitalizations and deaths. It's not that good against infections."
He also stated that Pfizer is submitting this data to the Food and Drug Administration.
Steven Danehy, a spokesperson for Pfizer, explained that Bourla is referring to preliminary data from a study done earlier this year. In it, the pharmaceutical company examined a fourth dose and a dose specifically targeting the Omicron variant, CBS News said.
"We will continue to collect and assess all available data," Danehy said in a statement, "and remain in open dialogue with regulators and health authorities to help inform a COVID-19 vaccine strategy as the virus evolves."
Bourla also shared that Pfizer is working on creating an entirely new vaccine to protect patients for at least a year against all variants.
"Omicron was the first one that was able to evade in a skillful way the immune protection that we're giving," he stated. "But also, we know that the duration of the protection doesn't last very long."
If a fourth dose is approved, it will be especially vital for people more susceptible to breakthrough infections.
Trending on Inside Edition
These Are the 10 Victims of the Buffalo Supermarket ShootingCrime
Woman Who Passed Out While Driving Reunited With Passersby Who Saved Her Through Police Department GiftsHuman Interest
'Exorcism' Death of 3-Year-Old Girl Leads to Arrest of Mother, Grandfather and UncleCrime
Indiana State Police Continue Investigation of Unidentified Boy Found Dead Inside SuitcaseCrime
Witness Says Accused Buffalo Gunman Came to Supermarket Day Before Massacre: 'Something Was Wrong With Him'Crime